Mulmit

ANAPTYSBIO, INCANAPTYSBIO, INC

ANAB Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31234,603,000226,902,000-13,232,000-0.44
2024-12-3191,280,00066,152,000-145,231,000-4.92
2023-12-3117,157,000-164,411,000-163,619,000-6.08
2022-12-3110,287,000-115,154,000-128,724,000-4.57
2021-12-3163,175,000-56,814,000-57,796,000-2.11

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-15Schmid John P.6,030
2026-06-15Schmid John P.6,030
2026-06-15Orwin John A6,030
2026-06-15Orwin John A6,030
2026-06-15RENTON HOLLINGS6,030
2026-06-15RENTON HOLLINGS6,030
2026-05-11Murphy Christopher M.Chief Financial Officer25,765
2026-05-11Hughes Owen11,250
2026-04-27GRAY SUSANNAH11,250
2026-04-20Faga DanielPresident, CEO11,000
2026-04-20Faga DanielPresident, CEO11,000
2026-04-20Faga DanielPresident, CEO2,321

8-K events

FiledItems
2026-08-11Submission of matters to a vote · Financial statements and exhibits
2026-07-30Regulation FD disclosure
2026-06-22Entry into a material agreement
2026-05-29Regulation FD disclosure
2026-05-21Amendments to charter or bylaws
2026-05-12Results of operations · Financial statements and exhibits
2026-05-11Officer or director change
2026-04-24Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.

한국 시장 대시보드Korea dashboard 미국·글로벌 대시보드US & Global dashboard